Prev：Combating atherosclerosis with chirality/phase dual‐engineered nanozyme featuring microenvironment‐programmed senolytic and senomorphic actions.(KTB1040-27)
Next：Combination anti-PD-1 and electroacupuncture induces a potent anti-tumor(A23710-)
